These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 20429345)

  • 1. [New options of influenza vaccination].
    Chlíbek R
    Cas Lek Cesk; 2010; 149(3):111-4. PubMed ID: 20429345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acceptance and opinions of Intanza/IDflu intradermal influenza vaccine in the Czech Republic and Turkey.
    Prymula R; Usluer G; Altinel S; Sichova R; Weber F
    Adv Ther; 2012 Jan; 29(1):41-52. PubMed ID: 22228256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and efficacy of a novel microneedle device for dose sparing intradermal influenza vaccination in healthy adults.
    Van Damme P; Oosterhuis-Kafeja F; Van der Wielen M; Almagor Y; Sharon O; Levin Y
    Vaccine; 2009 Jan; 27(3):454-9. PubMed ID: 19022318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluzone(®) Intradermal vaccine: a promising new chance to increase the acceptability of influenza vaccination in adults.
    Ansaldi F; de Florentiis D; Durando P; Icardi G
    Expert Rev Vaccines; 2012 Jan; 11(1):17-25. PubMed ID: 22149703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intradermal influenza vaccine administered using a new microinjection system produces superior immunogenicity in elderly adults: a randomized controlled trial.
    Holland D; Booy R; De Looze F; Eizenberg P; McDonald J; Karrasch J; McKeirnan M; Salem H; Mills G; Reid J; Weber F; Saville M
    J Infect Dis; 2008 Sep; 198(5):650-8. PubMed ID: 18652550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [From new vaccine to new target: revisiting influenza vaccination].
    Gérard M
    Rev Med Brux; 2011 Sep; 32(4):280-3. PubMed ID: 22034757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New emerging technologies and the intradermal route: the novel way to immunize against influenza.
    Falsey AR
    Vaccine; 2010 Sep; 28 Suppl 4():D24-32. PubMed ID: 20713257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prevention of influenza by use of intradermal vaccination].
    Kyncl J
    Cas Lek Cesk; 2009; 148(5):191-3. PubMed ID: 19642311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The influence of an event in the Israeli media on the compliance of patients with influenza vaccinations in the winter of 2006-2007].
    Perlman GY
    Harefuah; 2009 Dec; 148(12):811-4, 856. PubMed ID: 20088431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunogenicity and safety of intradermal influenza immunization at a reduced dose in healthy children.
    Chiu SS; Peiris JS; Chan KH; Wong WH; Lau YL
    Pediatrics; 2007 Jun; 119(6):1076-82. PubMed ID: 17545373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunogenicity and safety of low dose virosomal adjuvanted influenza vaccine administered intradermally compared to intramuscular full dose administration.
    Künzi V; Klap JM; Seiberling MK; Herzog C; Hartmann K; Kürsteiner O; Kompier R; Grimaldi R; Goudsmit J
    Vaccine; 2009 Jun; 27(27):3561-7. PubMed ID: 19464535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose sparing strategy with intradermal influenza vaccination in patients with solid cancer.
    Jo YM; Song JY; Hwang IS; Lee J; Oh SC; Kim JS; Kim SR; Kim WJ; Cheong HJ
    J Med Virol; 2009 Apr; 81(4):722-7. PubMed ID: 19235853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influenza vaccine immunogenicity in 6- to 23-month-old children: are identical antigens necessary for priming?
    Walter EB; Neuzil KM; Zhu Y; Fairchok MP; Gagliano ME; Monto AS; Englund JA
    Pediatrics; 2006 Sep; 118(3):e570-8. PubMed ID: 16950948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intradermal influenza vaccine for older adults: a randomized controlled multicenter phase III study.
    Arnou R; Icardi G; De Decker M; Ambrozaitis A; Kazek MP; Weber F; Van Damme P
    Vaccine; 2009 Dec; 27(52):7304-12. PubMed ID: 19849996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influenza vaccines provide diminished protection but are cost-saving in older adults.
    Deans GD; Stiver HG; McElhaney JE
    J Intern Med; 2010 Feb; 267(2):220-7. PubMed ID: 20175868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influenza vaccination coverage rates in five European countries-a population-based cross-sectional analysis of two consecutive influenza seasons.
    Szucs TD; Müller D
    Vaccine; 2005 Oct; 23(43):5055-63. PubMed ID: 16046035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved antibody responses in infants less than 1 year old using intradermal influenza vaccination.
    Sugimura T; Ito Y; Tananari Y; Ozaki Y; Maeno Y; Yamaoka T; Kudo Y
    Vaccine; 2008 May; 26(22):2700-5. PubMed ID: 18436353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intradermal influenza vaccination in immunocompromized patients is immunogenic and feasible.
    Gelinck LB; van den Bemt BJ; Marijt WA; van der Bijl AE; Visser LG; Cats HA; Rimmelzwaan GF; Kroon FP
    Vaccine; 2009 Apr; 27(18):2469-74. PubMed ID: 19368788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunogenicity and safety of intradermal versus intramuscular route of influenza immunization in infants less than 6 months of age: a randomized controlled trial.
    Chiu SS; Chan KH; Tu W; Lau YL; Peiris JS
    Vaccine; 2009 Jul; 27(35):4834-9. PubMed ID: 19523908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influenza vaccination coverage rates in 5 European countries: a population-based cross-sectional analysis of the seasons 02/03, 03/04 and 04/05.
    Müller D; Szucs TD
    Infection; 2007 Oct; 35(5):308-19. PubMed ID: 17885730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.